Publications by authors named "Chris Rhoades"

Claim this Profile
M
Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience.
David E Schuller, Enver Ozer, Amit Agrawal, John C Grecula, Chris A Rhoades

Arch Otolaryngol Head Neck Surg· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer.
Ewa Mrozek, Bhuvaneswari Ramaswamy, Donn Young, Chris A Rhoades, Kari Kendra

Clin Breast Cancer· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients.
Bhuvaneswari Ramaswamy, Anthony D Elias, Nicole T Kelbick, Angela Dodley, Mark Morrow, Chris Rhoades

Clin Cancer Res· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762).
Stuart M Lichtman, Donna Hollis, Antonius A Miller, Gary L Rosner, Chris A Rhoades

J Clin Oncol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results of a multimodal intensification regimen for previously untreated advanced resectable squamous cell cancer of the oral cavity, oropharynx, or hypopharynx.
Enver Ozer, John C Grecula, Amit Agrawal, Chris A Rhoades, Donn C Young

Laryngoscope· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensification regimen for advanced-stage resectable hypopharyngeal carcinoma.
Enver Ozer, John C Grecula, Amit Agrawal, Chris A Rhoades, David E Schuller

Arch Otolaryngol Head Neck Surg· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients.
J Paul Monk, Gary Phillips, Ross Waite, John Kuhn, Larry J Schaaf, Chris Rhoades

J Clin Oncol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III breast cancer.
Bhuvaneswari Ramaswamy, Steven P Povoski, Chris Rhoades, Joan Allen, Marsha Hauger

Breast Cancer Res Treat· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occult primary cancer clinical practice guidelines.
David S Ettinger, Juan P Arnoletti, Jon P Gockerman, Charles Handorf, Kathleen Anne Havlin, Chris A Rhoades

J Natl Compr Canc Netw· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
James P Malone, Julie A Stephens, John C Grecula, Chris A Rhoades, Bobak A Ghaheri

Head Neck· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro cytotoxic effects of stabilizing sugars within human intravenous immunoglobulin preparations against the human macrophage THP-1 cell-line.
Marc A Williams, Chris J Rhoades, Drew Provan, Adrian C Newland

Hematology· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal intensification therapy for previously untreated advanced resectable squamous cell carcinoma of the oral cavity, oropharynx, or hypopharynx.
David E Schuller, John C Grecula, Amit Agrawal, Chris A Rhoades, Debra A Orr

Cancer· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis